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(according to the authors’ assumptions) render the latter
superfluous. Figures 1 and 2 [1] show that a CSF leukocyte
count cutoff somewhere between 100 and 1000 provided a clean
separation of nonbacterial meningitis from proven and pre-
sumed bacterial meningitis, as would be expected given the
definitions used. Not addressed by the study was the more
realistic clinical quandary: which postoperative neurosurgical
patients who have a neutrophilic CSF pleocytosis but negative
CSF cultures truly need antimicrobial therapy. It would be in-
formative to know the outcomes for the patients from the pre-
sent study who had “presumed bacterial meningitis” but did
not receive antimicrobial therapy.
James R. Johnson
VA Medical Center and Department of Medicine,
University of Minnesota, Minneapolis, Minnesota
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Reply
SIR—We appreciate the comments of J. R. Johnson regarding
our study [1], which demonstrated higher predictive values for
CSF lactate (cutoff, 4 mmol/L) than CSF : blood glucose ratio
(cutoff, 0.4 mmol/L) for the diagnosis of bacterial meningitis
in neurosurgical patients. We agree that it would be clinically
important to study the outcome of patients with “presumed
bacterial meningitis” who did not receive antimicrobial therapy.
However, at the time that we performed our study, all patients
who qualified for our category “presumed bacterial meningitis”
received antimicrobial therapy. We planned and performed our
study because we had some doubt that leukocyte counts in the
CSF are reliable as a single test for the diagnosis of bacterial
meningitis in neurosurgical patients.
Neutrophilic CSF pleocytosis as a consequence of subarach-
noid-space inflammation is found in various infectious and non-
infectious forms of meningitis. The gold standard for the di-
agnosis of bacterial meningitis is the documentation of bacteria
in CSF by use of gram stain or culture. Both CSF leukocyte
count and documentation of microbial pathogens are incon-
clusive in patients who are receiving steroids or antimicrobial
therapy. In spontaneously occurring meningitis, CSF lactate
and CSF : blood glucose ratio have been found to discriminate
bacterial from nonbacterial causes of meningitis [2–7]. Neu-
rosurgery involving the posterior fossa can result in aseptic
meningitis (“posterior fossa syndrome”). Signs of meningeal
irritation appear rapidly, and although CSF analysis shows
polymorphonuclear pleocytosis with elevated protein and low
glucose mimicking bacterial meningitis, cultures remain nega-
tive. The obvious clinical dilemma is whether to treat these
patients with antimicrobial therapy or withhold it.
Standard CSF studies (i.e., gram stain, leukocyte counts, or
glucose and protein concentration) have proven unreliable for
the diagnosis of bacterial meningitis after neurosurgery [8].
Therefore, in addition to standard CSF analysis, CSF : blood
glucose ratio and CSF lactate levels are used in some centers
to help differentiate postoperative bacterial meningitis from
aseptic meningitis. In a retrospective study, we assessed which
of the 2 ancillary tests, CSF lactate or CSF : blood glucose
ratio, yielded better predictive values for the diagnosis of bac-
terial meningitis after neurosurgery. As correctly pointed out
by J. R. Johnson, CSF leukocyte count accurately discriminated
nonbacterial meningitis from presumed and proven bacterial
meningitis, as shown in figures 1 and 2. However, this obser-
vation does not render CSF lactate or CSF : blood glucose ratio
determination redundant, as the leukocyte count was used to
categorize patients into the predefined groups. Our study
showed that CSF lactate is superior to CSF : blood glucose
ratio for the diagnosis of post-neurosurgical bacterial menin-
gitis. This finding might prove helpful for designing a pro-
spective study, as suggested by J. R. Johnson, that addresses
the question: which patients need antimicrobial therapy?
Stephen L. Leib and Werner Zimmerli
Institute for Medical Microbiology, University of Bern,
and Division of Infectious Diseases, University Hospital,
Basel, Switzerland
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Impact of Infectious Diseases Specialists
SIR—The recent report of a study regarding the appropriateness
of antimicrobial therapy for bacteremia [1] and the accompa-
nying editorial [2] were disappointingly silent regarding the
study’s paradoxical and disturbing finding that although in-
fectious diseases specialists’ involvement was associated with
administration of more appropriate therapy, and appropriate
therapy was associated with improved survival, involvement of
infectious diseases specialists was not significantly associated
with improved survival. The authors’ speculations as to the
reasons for this lack of association would be welcome. Until
improved clinical outcomes from infectious diseases specialists’
involvement can be demonstrated, skeptics will remain uncon-
vinced that such specialists should routinely participate in the
management of treatment for patients with bacteremia (or other
infectious disease syndromes), regardless of improvements in
abstract process outcomes such as “appropriateness of ther-
apy.”
James R. Johnson
Veterans Affairs Medical Center and Department of Medicine,
University of Minnesota, Minneapolis, Minnesota
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Reply
SIR—We read with great interest the comments of J. R. John-
son, but we do not share his skepticism about the evaluation
of the benefit of the advice of infectious diseases specialists in
the management of bacteremic patients. Indeed, several factors
may explain why the involvement of an infectious disease spe-
cialist is not significantly associated with improved survival
among bacteremic patients, despite an increase in the appro-
priateness of therapy. First, we think, as do others, that phy-
sicians solicit the assistance of infectious disease specialists more
often in complicated cases, for which the prognosis is probably
worse [1]. In our series, 55% of patients about whom an in-
fectious disease specialist was consulted had already been
treated by antibiotics for a previous infection, compared with
only 38% of other patients ( ).P ! .01
Second, the relative risk of death related to infection is re-
duced by ∼30% for patients who are initially treated by infec-
tious disease specialists (group 1), compared with the risk for
patients who are initially treated by other physicians (group 2).
This improvement could probably have achieved a significant
threshold if more patients had been included, or if the treatment
of patients initially treated by other physicians with a poor rate
of appropriateness (group 2) had not been altered in subsequent
days by infectious disease specialists, which resulted in a higher
rate of appropriateness.
Indeed, of the 428 patients (groups 1 and 2), only 58 (14%)
were not followed by an infectious disease specialist between
the time of blood culture and the day on which the results of
susceptibility testing of the germ were available. This shift of
patients from group 2 to group 1 has 2 consequences. First,
the real impact of the infectious disease specialist on outcome
can be analyzed only for the empirical period, before the shift.
Second, from gram staining results, it can be seen that the
influence of the infectious disease specialist from day to day
resulted in more and more patient-treatments with greater ap-
propriateness than for other physicians at each step. As a con-
sequence, when the laboratory results are available, the result-
ing appropriateness of the treatment for nearly all the patients
is influenced by the advice of infectious disease specialists. This
also explains the ∼100% appropriateness of treatment when
susceptibility data became available in this series, in contrast
with the findings in other series cited in the discussion of our
article.
Moreover, the role of the infectious disease specialist in the
correct use of antimicrobial drugs is certainly of importance,
for both epidemiological and economic reasons. Although it
was not the primary end point of our study, we observed a
significant reduction in the use of broad-spectrum drugs by
infectious disease specialists compared with that by other
physicians.
For all these reasons, we think that our article, such as an-
other recently published in this journal [2], will help convince
our colleagues that patient-specific management advice from
infectious disease specialists will improve both the quality of
medical care and the outcome for patients.
